Abstract
Direct preparation of 2-amino-5,6,7,8-tetrahydro-4-(4-methoxyphenyl)-7,7-dimethyl-5-oxo-4H-chromene-3- carbonitrile (2) and 1,2-diamino-1,4,5,6,7,8-hexahydro-4-(4-methoxyphenyl)-7,7-dimethyl-5-oxo-3-quinolinecarbonitrile (11) which were utilized as starting products for the synthesis of S-nucleoside analogues of kinds 10, 15 and C-nucleoside analogues of types 12, 13 is presented in the current study. The antibacterial and antifungal activities of these new compounds were evaluated. The structures of the new products were confirmed on the basis of elemental and spectral analysis results.
Keywords: Chromeno[2, 3-b]pyridines, [1, 2, 4]triazolo[1, 5-a]quinolines, L-rhamnopyranosyl bromide, antimicrobial activity.
Letters in Organic Chemistry
Title:Synthesis of Some New Chromeno[2,3-b]pyridine and [1,2,4]Triazolo[1,5- a]quinoline Nucleoside Analogues with Expected Biological Activity
Volume: 12 Issue: 1
Author(s): Amira A. Ghoneim and Ahmed F. El-Farargy
Affiliation:
Keywords: Chromeno[2, 3-b]pyridines, [1, 2, 4]triazolo[1, 5-a]quinolines, L-rhamnopyranosyl bromide, antimicrobial activity.
Abstract: Direct preparation of 2-amino-5,6,7,8-tetrahydro-4-(4-methoxyphenyl)-7,7-dimethyl-5-oxo-4H-chromene-3- carbonitrile (2) and 1,2-diamino-1,4,5,6,7,8-hexahydro-4-(4-methoxyphenyl)-7,7-dimethyl-5-oxo-3-quinolinecarbonitrile (11) which were utilized as starting products for the synthesis of S-nucleoside analogues of kinds 10, 15 and C-nucleoside analogues of types 12, 13 is presented in the current study. The antibacterial and antifungal activities of these new compounds were evaluated. The structures of the new products were confirmed on the basis of elemental and spectral analysis results.
Export Options
About this article
Cite this article as:
Ghoneim A. Amira and El-Farargy F. Ahmed, Synthesis of Some New Chromeno[2,3-b]pyridine and [1,2,4]Triazolo[1,5- a]quinoline Nucleoside Analogues with Expected Biological Activity, Letters in Organic Chemistry 2015; 12 (1) . https://dx.doi.org/10.2174/1570178611666140304000403
DOI https://dx.doi.org/10.2174/1570178611666140304000403 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Usefulness of Magnetic Resonance Imaging in Cardiac and Enovascular Intervention
Current Medical Imaging Pharmacological Treatment of ADHD and the Short and Long Term Effects on Sleep
Current Pharmaceutical Design Endothelial Dysfunction in Sepsis
Current Vascular Pharmacology The Neuropharmacology of Cluster Headache and other Trigeminal Autonomic Cephalalgias
Current Neuropharmacology Polyvinyl Alcohol Nanofibers Blends as Drug Delivery System in Tissue Regeneration
Current Pharmaceutical Design Development of Calorie Restriction Mimetics as Therapeutics for Obesity, Diabetes, Inflammatory and Neurodegenerative Diseases
Current Genomics Refractory Behçet’s Disease with Multi-organ Involvement - Learning from Failure
Current Rheumatology Reviews α-Fibrinogenases
Current Drug Targets - Cardiovascular & Hematological Disorders Anti-Shock Garments for Obstetric Hemorrhage
Current Women`s Health Reviews Current Metabolomic Methodologies & their Application to Thermal Stress
Current Metabolomics GPR55 and its Interaction with Membrane Lipids: Comparison with Other Endocannabinoid-Binding Receptors
Current Medicinal Chemistry Outcomes of Patients with Chronic Heart Failure and Iron Deficiency Treated with Intravenous Iron: A Meta-analysis
Cardiovascular & Hematological Disorders-Drug Targets Isometric Handgrip Effects on Hypertension
Current Hypertension Reviews HIF Prolyl 4-Hydroxylases and their Potential as Drug Targets
Current Pharmaceutical Design Fourth Generation of Synthetic Cannabinoid Receptor Agonists: A Review on the Latest Insights
Current Pharmaceutical Design Type 1 11 β-hydroxysteroid Dehydrogenase as Universal Drug Target in Metabolic Diseases?
Endocrine, Metabolic & Immune Disorders - Drug Targets Synthesis, Spectral Characterization and Anticancer Activity of New 2,3,6- Substituted Quinazolin-4(3H)-one Derivatives
Letters in Organic Chemistry New Therapies in SLE
Recent Patents on Inflammation & Allergy Drug Discovery Toxicities of Immunosuppressive Treatment of Autoimmune Neurologic Diseases
Current Neuropharmacology Stress, Depression and Antidepressant Treatment Options in Patients Suffering from Multiple Sclerosis
Current Pharmaceutical Design